10894 Federal Register / Vol. 66, No. 34 / Tuesday, February 20, 2001 / Notices

above and reasonably identify the

record, specify the information being

contested, and state the corrective

action sought, with supporting

information to show how the record is

inaccurate, incomplete, untimely, or

irrelevant.

RECORD SOURCE CATEGORIES:

Information is provided by HHS

employees who apply for child care

subsidies. Furnishing of the information

is voluntary.

SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS

OF THE ACT:

None.

Appendix A

1. For employees of the Office of the

Secretary and the Administration on Aging,

nationwide, contact: Child Care Subsidy

Program Coordinator, PSC Work/Life Center,

Room 1250, 330 C Street, SW, Washington,

DC 20201.

2. For employees of the Substance Abuse

and Mental Health Services Administration,

contact: Director, Division of Human

Resources Management, Office of Program

Services, Substance Abuse and Mental

Health Services Administration, 5600 Fishers

Lane, Rockville, Maryland 20857.

3. For employees of the Food and Drug

Administration, nationwide, contact: Child

Care Subsidy Program Coordinator, Office of

Human Resources and Management Services,

Food and Drug Administration—HFA–410,

5600 Fishers Lane, Rockville, Maryland

20857.

4. For employees of the Program Support

Center, contact: Work & Family Coordinator,

Program Support Center, Room 1250, 330 C

Street SW, Washington, DC 20201.

[FR Doc. 01–4039 Filed 2–16–01; 8:45 am]

BILLING CODE 4150–04–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Agency for Healthcare Research and

Quality

Notice of Meeting

In accordance with section 10(d) of

the Federal Advisory Committee Act (5

U.S.C., Appendix 2), announcement is

made of the Special Emphasis Panel

meeting referenced below.

A Special Emphasis Panel (SEP) is a

committee of experts selected to conduct

scientific reviews of grant applications

submitted for agency funding that are related

to their areas of expertise. The committee

members are drawn from an agency list of

experts and are designated to serve for

particular individual meetings rather than for

extended fixed terms of service.

Substantial segments of the upcoming SEP

meeting listed below will be closed to the

public in accordance with the Federal

Advisory Committee Act, section 10(d) of 5

U.S.C., Appendix 2 and 5 U.S.C., 552b(c)(6).

Grant applications are to be reviewed and

discussed at this meeting. These discussions

are likely to include personal information

concerning individuals associated with the

applications. This information is exempt

from mandatory disclosure under the abovecited statutes.

1. Name of SEP: Health Research

Dissemination & Implementation.

Date: March 5, 2001 (Open from 8 a.m. to

8:15 a.m. and closed for the remainder of the

meeting).

Place: 6010 Building, 4th Floor,

Conference Room D, Rockville, Maryland

20852.

Contact Person: Anyone wishing to obtain

a roster of members or minutes of this

meeting should contact Ms. Jenny Griffith,

Committee Management Officer, Office of

Research Review, Education and Policy,

AHRQ, 2101 East Jefferson Street, Suite 400,

Rockville, Maryland 20852, Telephone (301)

594–1847.

Agenda items for this meeting are subject

to change as priorities dictate.

Dated: February 13, 2001.

John M. Eisenberg,

Director.

[FR Doc. 01–4148 Filed 2–16–01; 8:45 am]

BILLING CODE 4160–90–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Childhood

Lead Poisoning Prevention: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC) announces the

following committee meeting.

Name: Advisory Committee on Childhood

Lead Poisoning Prevention.

Times and Dates: 8:30 a.m.—5:15 p.m.,

February 27, 2001; 8:30 a.m.—12:15 p.m.,

February 28, 2001.

Place: Swissotel Atlanta Hotel, 3391

Peachtree Road, N.E., Atlanta, Georgia 30326,

telephone 404/365–0065.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 90 people.

Purpose: The Committee shall provide

advice and guidance to the Secretary; the

Assistant Secretary for Health; and the

Director, CDC, regarding new scientific

knowledge and technological developments

and their practical implications for

childhood lead poisoning prevention efforts.

The Committee shall also review and report

regularly on childhood lead poisoning

prevention practices and recommend

improvements in national childhood lead

poisoning prevention efforts.

Matters to be Discussed: Agenda items

include: Updates on Medicaid Targeted

Screening issues, Case Management issues,

EPA, and MMWR Publication Process,

Treatment of Lead-Exposed Children Trial

Presentation, and discussion of future topics.

Agenda items are subject to change as

priorities dictate.

Opportunities will be provided during the

meeting for oral comments. Depending on the

time available and the number of requests, it

may be necessary to limit the time of each

presenter.

This notice is published less than 15 days

prior to the meeting due to administrative

delays.

Contact Person for More Information:

Becky Wright, Program Analyst, Lead

Poisoning Prevention Branch, Division of

Environmental Hazards and Health Effects,

NCEH, CDC, 1600 Clifton Road, NE, M/S E–

25, Atlanta, Georgia 30333, telephone 404/

639–1789, fax 404/639–2570.

The Director, Management Analysis and

Services office has been delegated the

authority to sign Federal Register notices

pertaining to announcements of meetings and

other committee management activities, for

both the Centers for Disease Control and

Prevention and the Agency for Toxic

Substances and Disease Registry.

Dated: February 13, 2001.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention.

[FR Doc. 01–4101 Filed 2–16–01; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Vaccines and Related Biological

Products Advisory Committee; Notice

of Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

This notice announces a forthcoming

meeting of a public advisory committee

of the Food and Drug Administration

(FDA). At least one portion of the

meeting will be closed to the public.

Name of Committee: Vaccines and Related

Biological Products Advisory Committee.

General Function of the Committee: To

provide advice and recommendations to the

agency on FDA’s regulatory issues.

Date and Time: The meeting will be held

on March 7, 2001, from 8 a.m. to 6:30 p.m.,

March 8, 2001, from 8 a.m. to 6:30 p.m., and

March 9, 2001, from 8 a.m. to 12:30 p.m.

Location: Holiday Inn, Versailles

Ballrooms I and II, 8120 Wisconsin Ave.,

Bethesda, MD.

Contact: Nancy T. Cherry or Denise H.

Royster, Center for Biologics Evaluation and

Research (HFM 71), Food and Drug

Administration, 1401 Rockville Pike,

Rockville, MD 20852, or FDA Advisory